Whole genome sequencing of 45 Japanese patients with intellectual disability

Intellectual disability (ID) is characterized by significant limitations in both intellectual functioning and adaptive behaviors, originating before the age of 18 years. However, the genetic etiologies of ID are still incompletely elucidated due to the wide range of clinical and genetic heterogeneit...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:American journal of medical genetics. Part A Ročník 185; číslo 5; s. 1468 - 1480
Hlavní autoři: Abe‐Hatano, Chihiro, Iida, Aritoshi, Kosugi, Shunichi, Momozawa, Yukihide, Terao, Chikashi, Ishikawa, Keiko, Okubo, Mariko, Hachiya, Yasuo, Nishida, Hiroya, Nakamura, Kazuyuki, Miyata, Rie, Murakami, Chie, Takahashi, Kan, Hoshino, Kyoko, Sakamoto, Haruko, Ohta, Sayaka, Kubota, Masaya, Takeshita, Eri, Ishiyama, Akihiko, Nakagawa, Eiji, Sasaki, Masayuki, Kato, Mitsuhiro, Matsumoto, Naomichi, Kamatani, Yoichiro, Kubo, Michiaki, Takahashi, Yoshiyuki, Natsume, Jun, Inoue, Ken, Goto, Yu‐Ichi
Médium: Journal Article
Jazyk:angličtina
Vydáno: Hoboken, USA John Wiley & Sons, Inc 01.05.2021
Wiley Subscription Services, Inc
Wiley
Témata:
ISSN:1552-4825, 1552-4833, 1552-4833
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Intellectual disability (ID) is characterized by significant limitations in both intellectual functioning and adaptive behaviors, originating before the age of 18 years. However, the genetic etiologies of ID are still incompletely elucidated due to the wide range of clinical and genetic heterogeneity. Whole genome sequencing (WGS) has been applied as a single‐step clinical diagnostic tool for ID because it detects genetic variations with a wide range of resolution from single nucleotide variants (SNVs) to structural variants (SVs). To explore the causative genes for ID, we employed WGS in 45 patients from 44 unrelated Japanese families and performed a stepwise screening approach focusing on the coding variants in the genes. Here, we report 12 pathogenic and likely pathogenic variants: seven heterozygous variants of ADNP, SATB2, ANKRD11, PTEN, TCF4, SPAST, and KCNA2, three hemizygous variants of SMS, SLC6A8, and IQSEC2, and one homozygous variant in AGTPBP1. Of these, four were considered novel. Furthermore, a novel 76 kb deletion containing exons 1 and 2 in DYRK1A was identified. We confirmed the clinical and genetic heterogeneity and high frequency of de novo causative variants (8/12, 66.7%). This is the first report of WGS analysis in Japanese patients with ID. Our results would provide insight into the correlation between novel variants and expanded phenotypes of the disease.
Bibliografie:Funding information
Intramural Research Grants for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry, Japan, Grant/Award Number: 27‐6 30‐7 to Y.G.; 30‐9 to A.I.; Joint Usage and Joint Research Programs, the Institute of Advanced Medical Sciences, Tokushima University, Grant/Award Number: 2020, 2A19 to A.I.; the Construction of Integrated Database of Clinical and Genomics Information and Sustainable System for Promoting Genomic Medicine in Japan from the Japan Agency for Medical Research and Development, AMED, Grant/Award Number: 18kk0205012s0303 to Y.G.; the Platform Program for Promotion of Genome Medicine from the Japan Agency for Medical Research and Development, AMED, Grant/Award Number: 17km0405104h0005 to Y.G.; the Program for an Integrated Database of Clinical and Genomic Information from the Japan Agency for Medical Research and Development, AMED, Grant/Award Number: 17kk0205012h0002 to Y.G.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC8247954
Funding information Intramural Research Grants for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry, Japan, Grant/Award Number: 27‐6 30‐7 to Y.G.; 30‐9 to A.I.; Joint Usage and Joint Research Programs, the Institute of Advanced Medical Sciences, Tokushima University, Grant/Award Number: 2020, 2A19 to A.I.; the Construction of Integrated Database of Clinical and Genomics Information and Sustainable System for Promoting Genomic Medicine in Japan from the Japan Agency for Medical Research and Development, AMED, Grant/Award Number: 18kk0205012s0303 to Y.G.; the Platform Program for Promotion of Genome Medicine from the Japan Agency for Medical Research and Development, AMED, Grant/Award Number: 17km0405104h0005 to Y.G.; the Program for an Integrated Database of Clinical and Genomic Information from the Japan Agency for Medical Research and Development, AMED, Grant/Award Number: 17kk0205012h0002 to Y.G.
ISSN:1552-4825
1552-4833
1552-4833
DOI:10.1002/ajmg.a.62138